Knowledge, attitudes and preferences regarding genetic testing for smoking cessation. A cross-sectional survey among Dutch smokers

Marieke Quaak, Chris Smerecnik, Frederik J van Schooten, Hein de Vries, Constant P van Schayck, Marieke Quaak, Chris Smerecnik, Frederik J van Schooten, Hein de Vries, Constant P van Schayck

Abstract

Objectives Recent research strongly suggests that genetic variation influences smokers' ability to stop. Therefore, the use of (pharmaco) genetic testing may increase cessation rates. This study aims to assess the intention of smokers concerning undergoing genetic testing for smoking cessation and their knowledge, attitudes and preferences about this subject. Design Online cross-sectional survey. Setting Database internet research company of which every inhabitant of the Netherlands of ≥12 years with an email address and capable of understanding Dutch can become a member. Participants 587 of 711 Dutch smokers aged ≥18 years, daily smokers for ≥5 years and smoke on average ≥10 cigarettes/day (response rate=83%). Primary and secondary outcome measures Smokers' knowledge, attitudes and preferences and their intention to undergo genetic testing for smoking cessation. Results Knowledge on the influence of genetic factors in smoking addiction and cessation was found to be low. Smokers underestimated their chances of having a genetic predisposition and the influence of this on smoking cessation. Participants perceived few disadvantages, some advantages and showed moderate self-efficacy towards undergoing a genetic test and dealing with the results. Smokers were mildly interested in receiving information and participating in genetic testing, especially when offered by their general practitioner (GP). Conclusions For successful implementation of genetic testing for smoking in general practice, several issues should be addressed, such as the knowledge on smoking cessation, genetics and genetic testing (including advantages and disadvantages) and the influence of genetics on smoking addiction and cessation. Furthermore, smokers allocate their GPs a crucial role in the provision of information and the delivery of a genetic test for smoking; however, it is unclear whether GPs will be able and willing to take on this role.

Conflict of interest statement

Competing interests: CPvS reported having received financing (grant, consultancy and/or travel/accommodation costs) from AstraZeneca, Boehringer Ingelheim and Pfizer, unrelated to this study. MQ, CS, HdV and FJvS declare no conflicts of interest.

References

    1. Guindon GE, Boisclair D. Past, Current and Future Trends in Tobacco Use. HNP Discussion Paper no.6. Economics of Tobacco Control Paper No. 6. UC San Francisco: WHO Tobacco Control Papers, Center for Tobacco Control Research and Education, 2003
    1. World Health Organization The World Health Report 2003-Shaping the Future. Geneva: World Health Organization, 2003
    1. Mucha L, Stephenson J, Morandi N, et al. Meta-analysis of disease risk associated with smoking, by gender and intensity of smoking. Gend Med 2006;3:279–91
    1. Taylor DH, Jr, Hasselblad V, Henley SJ, et al. Benefits of smoking cessation for longevity. Am J Public Health 2002;92:990–6
    1. Quaak M, van Schayck CP, Knaapen AM, et al. Genetic variation as a predictor of smoking cessation success. A promising preventive and intervention tool for chronic respiratory diseases? Eur Respir J 2009;33:468–80
    1. Batra V, Patkar AA, Berrettini WH, et al. The genetic determinants of smoking. Chest 2003;123:1730–9
    1. Li MD, Cheng R, Ma JZ, et al. A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction 2003;98:23–31
    1. Munafò MR, Johnstone EC. Genes and cigarette smoking. Addiction 2008;103:893–904
    1. Kaprio J. Genetic epidemiology of smoking behavior and nicotine dependence. COPD 2009;6:304–6
    1. Kortmann GL, Dobler CJ, Bizarro L, et al. Pharmacogenetics of smoking cessation therapy. Am J Med Genet B Neuropsychiatr Genet 2010;153B:17–28
    1. Quaak M, van Schayck CP, Knaapen AM, et al. Implications of gene-drug interactions in smoking cessation for improving the prevention of chronic degenerative diseases. Mutat Res 2009;667:44–57
    1. Heatherton TF, Kozlowski LT, Frecker RC, et al. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict 1991;86:1119–27
    1. Houfek JF, Atwood JR, Wolfe RM, et al. Knowledge and beliefs about genetics and smoking among visitors and staff at a health care facility. Public Health Nurs 2008;25:77–87
    1. Lerman C, Caporaso NE, Audrain J, et al. Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychol 1999;18:14–20
    1. Smerecnik C, Quaak M, van Schayck CP, et al. Are smokers interested in genetic testing for smoking addiction? A socio-cognitive approach. Psychol Health 2011;26:1099–112
    1. Lapham EV, Kozma C, Weiss JO. Genetic discrimination: perspectives of consumers. Science 1996;274:621–4
    1. Hall MA, McEwen JE, Barton JC, et al. Concerns in a primary care population about genetic discrimination by insurers. Genet Med 2005;7:311–16
    1. Murthy A, Dixon A, Mossialos E. Genetic testing and insurance. J R Soc Med 2001;94:57–60
    1. Baars MJ, Henneman L, Ten Kate LP. Deficiency of knowledge of genetics and genetic tests among general practitioners, gynecologists, and pediatricians: a global problem. Genet Med 2005;7:605–10
    1. Shields AE, Blumenthal D, Weiss KB, et al. Barriers to translating emerging genetic research on smoking into clinical practice. Perspectives of primary care physicians. J Gen Intern Med 2005;20:131–8
    1. Park ER, Kleimann S, Pelan JA, et al. Anticipating clinical integration of genetically tailored tobacco dependence treatment: perspectives of primary care physicians. Nicotine Tob Res 2007;9:271–9
    1. Suther S, Goodson P. Barriers to the provision of genetic services by primary care physicians: a systematic review of the literature. Genet Med 2003;5:70–6
    1. Sanderson SC, O'Neill SC, Bastian LA, et al. What can interest tell us about uptake of genetic testing? Intention and behavior amongst smokers related to patients with lung cancer. Public Health Genomics 2010;13:116–24
    1. Krantz JH, Ballard J, Scher J. Comparing the results of laboratory and World-Wide Web samples on the determinants of female attractiveness. Behav Res Methods Instrum Comput 1997;29:264–9
    1. Buchanan T, Smith JL. Using the Internet for psychological research: personality testing on the World Wide Web. Br J Psychol 1999;90:125–44
    1. Buchanan T, Smith JL. Research on the Internet: validation of a World-Wide Web mediated personality scale. Behav Res Methods Instrum Comput 1999;31:565–71
    1. Nathanson AT, Reinert SE. Windsurfing injuries: results of a paper- and Internet-based survey. Wilderness Environ Med 1999;10:218–25
    1. Senior C, Phillips ML, Barnes J, et al. An investigation into the perception of dominance from schematic faces: a study using the World-Wide Web. Behav Res Methods Instrum Comput 1999;31:341–6

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren